These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3392422)

  • 1. Single, large, daily dosing versus intermittent dosing of tobramycin for treating experimental pseudomonas pneumonia.
    Kapusnik JE; Hackbarth CJ; Chambers HF; Carpenter T; Sande MA
    J Infect Dis; 1988 Jul; 158(1):7-12. PubMed ID: 3392422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenging conventional aminoglycoside dosing regimens. The value of experimental models.
    Kapusnik JE; Sande MA
    Am J Med; 1986 Jun; 80(6B):179-81. PubMed ID: 3089001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single versus combination antibiotic therapy for pneumonia due to Pseudomonas aeruginosa in neutropenic guinea pigs.
    Rusnak MG; Drake TA; Hackbarth CJ; Sande MA
    J Infect Dis; 1984 Jun; 149(6):980-5. PubMed ID: 6429255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic treatment of experimental Pseudomonas aeruginosa pneumonia in guinea pigs: comparison of aerosol and systemic administration.
    Makhoul IR; Merzbach D; Lichtig C; Berant M
    J Infect Dis; 1993 Nov; 168(5):1296-9. PubMed ID: 8228367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-daily vs. continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin, and tobramycin.
    Powell SH; Thompson WL; Luthe MA; Stern RC; Grossniklaus DA; Bloxham DD; Groden DL; Jacobs MR; DiScenna AO; Cash HA; Klinger JD
    J Infect Dis; 1983 May; 147(5):918-32. PubMed ID: 6860416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel approaches for the use of aminoglycosides: the value of experimental models.
    Kapusnik JE; Sande MA
    J Antimicrob Chemother; 1986 Mar; 17 Suppl A():7-10. PubMed ID: 3710965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Pharmacokinetic/Pharmacodynamic Model-Based Optimized Combination Regimens against Multidrug-Resistant Pseudomonas aeruginosa in a Murine Thigh Infection Model by Using Humanized Dosing Schemes.
    Yadav R; Bulitta JB; Wang J; Nation RL; Landersdorfer CB
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative activities of N-formimidoyl thienamycin, ticarcillin, and tobramycin against experimental Pseudomonas aeruginosa pneumonia.
    Pennington JE; Johnson CE
    Antimicrob Agents Chemother; 1982 Sep; 22(3):406-8. PubMed ID: 6814354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passive immune therapy for experimental Pseudomonas aeruginosa pneumonia in the neutropenic host.
    Pennington JE; Small GJ
    J Infect Dis; 1987 May; 155(5):973-8. PubMed ID: 3104484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized study of tobramycin plus ticarcillin, tobramycin plus cephalothin and ticarcillin, or tobramycin plus mezlocillin in the treatment of infection in neutropenic patients with malignancies.
    Lawson RD; Gentry LO; Bodey GP; Keating MJ; Smith TL
    Am J Med Sci; 1984; 287(1):16-23. PubMed ID: 6367466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacies of piperacillin, azlocillin, ticarcillin, aztreonam, and tobramycin against experimental Pseudomonas aeruginosa pneumonia.
    Schiff JB; Pennington JE
    Antimicrob Agents Chemother; 1984 Jan; 25(1):49-52. PubMed ID: 6538397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative activities of ciprofloxacin, ticarcillin, and tobramycin against experimental Pseudomonas aeruginosa pneumonia.
    Schiff JB; Small GJ; Pennington JE
    Antimicrob Agents Chemother; 1984 Jul; 26(1):1-4. PubMed ID: 6433786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefoperazone plus piperacillin versus mezlocillin plus tobramycin as empiric therapy for febrile episodes in neutropenic patients.
    Rotstein C; Cimino M; Winkey K; Cesari C; Fenner J
    Am J Med; 1988 Jul; 85(1A):36-43. PubMed ID: 3041817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of combination chemotherapy in a lightly anesthetized animal model of Pseudomonas pneumonia.
    Gordin FM; Rusnak MG; Sande MA
    Antimicrob Agents Chemother; 1987 Mar; 31(3):398-403. PubMed ID: 3107461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative analysis of aztreonam + clindamycin versus tobramycin + clindamycin or amikacin + mezlocillin in the treatment of gram-negative lower respiratory tract infections.
    Rivera-Vazquez CR; Ramirez-Ronda CH; Rodriguez JR; Saavedra S
    Chemotherapy; 1989; 35 Suppl 1():89-100. PubMed ID: 2659296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of 6 and 8 hourly tobramycin dosing intervals in treatment of pulmonary exacerbations in cystic fibrosis patients.
    Winnie GB; Cooper JA; Witson J; Cowan RG; Mayer D; Lepow M
    Pediatr Infect Dis J; 1991 May; 10(5):381-6. PubMed ID: 1906161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental Pseudomonas aeruginosa sepsis: absence of synergy between ticarcillin and tobramycin.
    Chusid MJ; Davis SD; Sarff LD
    J Lab Clin Med; 1983 Mar; 101(3):441-9. PubMed ID: 6402553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of aerosolized tobramycin in the treatment of a resistant pseudomonal pneumonitis.
    McCall CY; Spruill WJ; Wade WE
    Ther Drug Monit; 1989 Nov; 11(6):692-5. PubMed ID: 2595751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased dosage requirements of tobramycin and gentamicin for treating Pseudomonas pneumonia in patients with cystic fibrosis.
    Mann HJ; Canafax DM; Cipolle RJ; Daniels CE; Zaske DE; Warwick WJ
    Pediatr Pulmonol; 1985; 1(5):238-43. PubMed ID: 4069813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous infusion tobramycin combined with carbenicillin for infections in cancer patients.
    Issell BF; Keating MJ; Valdivieso M; Bodey GP
    Am J Med Sci; 1979; 277(3):311-8. PubMed ID: 256433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.